“Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders” (2020) Indian Journal of Public Health Research & Development, 11(8), pp. 206–213. doi:10.37506/ijphrd.v11i8.10923.